Difference between revisions of "Valganciclovir (Valcyte)"
Jump to navigation
Jump to search
(Created page with "Antiviral with particular activity against cytomegalovirus (CMV). Category:Drug index Category:Antivirals Category:DNA synthesis inhibitors Category:Drugs FDA a...") |
m (→Also known as) |
||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
Antiviral with particular activity against cytomegalovirus (CMV). | Antiviral with particular activity against cytomegalovirus (CMV). | ||
| − | [[Category: | + | ==Also known as== |
| − | [[Category: | + | *'''Brand names:''' Cytomega, VagaCyte, Valcyclovir, Valcyte, Valgan, Valixa, Valnov, Virolfi, V-Gavir |
| − | [[Category:DNA synthesis inhibitors]] | + | |
| − | [[Category: | + | [[Category:Drugs]] |
| + | [[Category:Oral medications]] | ||
| + | [[Category:Viral DNA synthesis inhibitors]] | ||
| + | [[Category:FDA approved in 2001]] | ||
Latest revision as of 18:20, 27 February 2020
Antiviral with particular activity against cytomegalovirus (CMV).
Also known as
- Brand names: Cytomega, VagaCyte, Valcyclovir, Valcyte, Valgan, Valixa, Valnov, Virolfi, V-Gavir